New options for early treatment of multiple sclerosis-Reference-Cited by-同舟云学术

New options for early treatment of multiple sclerosis

Published:2009-02 Issue: Volume:277 Page:S9-S11
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Tintoré Mar

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology

Reference15 articles.

1. Rationale for early intervention with immunomodulatory treatments;Tintoré;J Neurol,2008

2. Early glatiramer acetate treatment in delaying conversion to clinically definite multiple sclerosis (CDMS) in subjects presenting with a clinically isolated syndrome;Comi;Neurology,2008

3. New diagnostic criteria for multiple sclerosis: guidelines for research protocols;Poser;Ann Neurol,1983

5. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”;Polman;Ann Neurol,2005

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disability progression in multiple sclerosis patients using early first‐line treatments;European Journal of Neurology;2022-06-11

2. Treatment withdrawal in relapsing−remitting multiple sclerosis: a retrospective cohort study;European Journal of Neurology;2015-07-26

3. Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis;Neuropsychiatric Disease and Treatment;2013-06

4. Peptide and protein based pharmaceuticals;Amino Acids, Peptides and Proteins;2013

5. MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study;Journal of Neurology;2012-12-21